Abstract
Comparative results of the study of the biological distribution of 68Ga incorporated in NODA aminoglucose in mice organs and tissues with the experimental model of malignant tumor and aseptic inflammation are presented. It is revealed that pathological conditions have no significant effect on the 68Ga-NODA aminoglucose behavior after intravenous administration. The dynamics of activity accumulation and excretion in most organs and tissues had no significant differences. The level of activity accumulation in tumor and muscular tissue with inflammation at 1 h after injection of 68Ga-NODA-aminoglucose exceeded the same values in other organs and tissues, except kidneys. The obtained results show the promising application of 68Ga-NODA- aminoglucose for imaging pathological lesions by positron emission tomography.
Similar content being viewed by others
REFERENCES
W. T. Rahman, D. J. Wale, B. L. Viglianti, D. M. Townsend, M. S. Manganaro, M. D. Goss, K. K. Wong, and D. Rubello, “The Impact of Infection and Inflammation in Oncologic 18F-FDG PET/CT Imaging,” Biomed. Pharmacother. 117, 109168 (2019).
M. S. Tlostanova, “Efficiency of Positron Emission Tomography with 18F-Fluorodeoxyglucose, 11C-Methionine, and 82Rb-Chloride in Differential Diagnosis of Lung Tumors and Some Inflammatory Pulmonary Diseases,” Mod. Technol. Med. 6(3), 45 (2014).
S. Vaidyanathan, C. N. Patel, A. F. Scarsbrook, and F. U. Chowdhury, “FDG PET/CT in Infection and Inflammation–Current and Emerging Clinical Applications,” Clin. Radiol. 70, 787 (2015). https://doi.org/10.1016/j.crad.2015.03.010
V. M. Petriev, V. K. Tishchenko, and R. N. Krasikova, “18F-FDG and Other Labeled Glucose Derivatives for Use in Radionuclide Diagnosis of Oncological Diseases (Review),” Pharm. Chem. J. 50, 209 (2016). https://doi.org/10.1007/s11094-016-1425-y
V. M. Petriev, V. K. Tishchenko, E. D. Stepchenkova, I. N. Zavestovskaya, P. V. Shegai, S. A. Ivanov, and A. D. Karpin, “Effect of Gallium Carrier in 68Ga-Ethylenediaminetetrakis (Methylene Phosphonic Acid) on Its Behavior in Laboratory Animals,” Bull. Lebedev Phys. Inst. 46, 319 (2019). https://doi.org/10.3103/S1068335619100051
V. K. Tishchenko, V. M. Petriev, A. A. Mikhailovskaya, E. D. Stepchenkova, V. Yu. Timoshenko, A. A. Postnov, and I. N. Zavestovskaya, “Experimental Study of the Biodistribution of New Bone-Seeking Compounds Based on Phosphonic Acids and Gallium-68,” Bull. Exp. Biol. Med. 168, 739 (2019). htts://doi.org/https://doi.org/10.1007/s10517-020-04800-1
V. M. Petriev, V. K. Tishchenko, O. A. Smoryzanova, I. N. Zavestovskaya, and A. A. Postnov, “Complex Compounds of Rhenium-188 and Gallium-68 Radionuclides and Their Behavior in the Organism of Laboratory Animals,” Bull. Lebedev Phys. Inst. 46, 58 (2019). https://doi.org/10.3103/S1068335619020052
Y. H. Zhang, J. Bryant, F. L. Kong, D. F. Yu, R. Mendez, E. E. Kim, and D. J. Yang, “Molecular Imaging of Mesothelioma with 99mTc-ECG and 68Ga-ECG,” J. Biomed. Biothecnol. 2012, ID 232863 (2012). https://doi.org/10.1155/2012/232863
Z. Yang, C. Xiong, R. Zhang, H. Zhu, and C. Li, “Synthesis and Evaluation of 68Ga-labeled DOTA-2-Deoxy-D-Glucosamine as a Potential Radiotracer in µPET Imaging,” Am. J. Nucl. Med. Mol. Imaging. 2, 499 (2012).
Funding
This study was supported by the Ministry of Science and Higher Education of the Russian Federation (agreement no. 075-02-2018-097, November 26, 2018), project no. RFMEFI57518X0174.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Translated by A. Kazantsev
About this article
Cite this article
Tishchenko, V.K., Petriev, V.M., Fedorova, A.V. et al. Behavior of gallium-68 incorporated in NODA aminoglucose in laboratory animals with various pathological processes. Bull. Lebedev Phys. Inst. 47, 213–217 (2020). https://doi.org/10.3103/S1068335620070064
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S1068335620070064